Cargando…

Development of peptidomimetic ligands of Pro-Leu-Gly-NH(2) as allosteric modulators of the dopamine D(2) receptor

A variety of stable, small-molecule peptidomimetic ligands have been developed to elucidate the mechanism by which the neuropeptide Pro-Leu-Gly-NH(2) (PLG) modulates dopaminergic neurotransmission. Photoaffinity labeling ligands based upon PLG peptidomimetics have been used to establish that PLG bin...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bhagwanth, Swapna, Mishra, Ram K, Johnson, Rodney L
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Beilstein-Institut 2013
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3566759/ https://www.ncbi.nlm.nih.gov/pubmed/23400263 http://dx.doi.org/10.3762/bjoc.9.24

Ejemplares similares

Brain Activation by Peptide Pro-Leu-Gly-NH(2) (MIF-1)
por: Khan, Reas S., et al.
Publicado: (2010)

G(s) protein peptidomimetics as allosteric modulators of the β(2)-adrenergic receptor
por: Boyhus, Lotte-Emilie, et al.
Publicado: (2018)

Effects of the Dopamine D2 Allosteric Modulator, PAOPA, on the Expression of GRK2, Arrestin-3, ERK1/2, and on Receptor Internalization
por: Basu, Dipannita, et al.
Publicado: (2013)

Allosteric Modulator Leads Hiding in Plain Site: Developing Peptide and Peptidomimetics as GPCR Allosteric Modulators
por: Olson, Keith M., et al.
Publicado: (2021)

The Antagonist pGlu-βGlu-Pro-NH(2) Binds to an Allosteric Site of the Thyrotropin-Releasing Hormone Receptor
por: De La Cruz, Daniel L., et al.
Publicado: (2021)

Stereoselective synthesis of Gly-Gly-type (E)-methylalkene and (Z)-chloroalkene dipeptide isosteres and their application to 14-mer RGG peptidomimetics
por: Okita, Hikari, et al.
Publicado: (2020)

Pressure Dependence of (15)N Chemical Shifts in Model Peptides Ac-Gly-Gly-X-Ala-NH(2)
por: Koehler, Joerg, et al.
Publicado: (2012)

Shared dynamics of LeuT superfamily members and allosteric differentiation by structural irregularities and multimerization
por: Ponzoni, Luca, et al.
Publicado: (2018)

Genotype-phenotype correlations of TGFBI p.Leu509Pro, p.Leu509Arg, p.Val613Gly, and the allelic association of p.Met502Val-p.Arg555Gln mutations
por: Niel-Butschi, Florence, et al.
Publicado: (2011)

Pro and Gly for elasticity
por: LeBrasseur, Nicole
Publicado: (2006)

Discovery of SARS-CoV-2 3CL(Pro) Peptidomimetic Inhibitors through the Catalytic Dyad Histidine-Specific Protein–Ligand Interactions
por: Wang, Yaxin, et al.
Publicado: (2022)

In vivo Anti-inflammatory Activity of Lipidated Peptidomimetics Pam-(Lys-βNspe)(6)-NH(2) and Lau-(Lys-βNspe)(6)-NH(2) Against PMA-Induced Acute Inflammation
por: Wu, Bing C., et al.
Publicado: (2020)

The Role of Lipids in Allosteric Modulation of Dopamine D(2) Receptor—In Silico Study
por: Żuk, Justyna, et al.
Publicado: (2022)

Complex formation constant of ferric ion with Gly, Pro-Hyp and Gly-Pro-Hyp
por: Zhi, Mingyu, et al.
Publicado: (2018)

Conformational dynamics of ligand-dependent alternating access in LeuT
por: Kazmier, Kelli, et al.
Publicado: (2014)

Mechanism of dopamine binding and allosteric modulation of the human D1 dopamine receptor
por: Zhuang, Youwen, et al.
Publicado: (2021)

Evaluation of in vitro toxicity of peptide (N-acetyl-Leu-Gly-Leu-COOH)-substituted-β-cyclodextrin derivative, a novel drug carrier, in PC-12 cells
por: Sadeghnia, Hamid Reza, et al.
Publicado: (2013)

Theragra chalcogramma Hydrolysate, Rich in Gly-Leu-Pro-Ser-Tyr-Thr, Alleviates Photoaging via Modulating Deposition of Collagen Fibers and Restoration of Extracellular Components Matrix in SD Rats
por: Xu, Defeng, et al.
Publicado: (2022)

Pressure dependence of side chain (1)H and (15)N-chemical shifts in the model peptides Ac-Gly-Gly-Xxx-Ala-NH(2)
por: Beck Erlach, Markus, et al.
Publicado: (2020)

Thermostabilization and purification of the human dopamine transporter (hDAT) in an inhibitor and allosteric ligand bound conformation
por: Navratna, Vikas, et al.
Publicado: (2018)

Identification of an allosteric binding site on the human glycine transporter, GlyT2, for bioactive lipid analgesics
por: Mostyn, Shannon N, et al.
Publicado: (2019)

SARS-CoV-2 M(pro): A Potential Target for Peptidomimetics and Small-Molecule Inhibitors
por: Citarella, Andrea, et al.
Publicado: (2021)

The biological characteristics of SARS-CoV-2 spike protein Pro330-Leu650
por: Su, Qiu-dong, et al.
Publicado: (2020)

Peptidomimetics II
por: Lubell, William D
Publicado: (2016)

Solid-Phase Synthesis of Gly-Ψ[CH(CF(3))NH]-Peptides
por: Sgorbati, Clara, et al.
Publicado: (2021)

Allosteric modulation of dopamine D(2L) receptor in complex with G(i1) and G(i2) proteins: the effect of subtle structural and stereochemical ligand modifications
por: Żuk, Justyna, et al.
Publicado: (2022)

Development and Evaluation of Small Peptidomimetic Ligands to Protease-Activated Receptor-2 (PAR(2)) through the Use of Lipid Tethering
por: Boitano, Scott, et al.
Publicado: (2014)

Peptidomimetic-based antibody surrogate for HER2
por: Zheng, Mengmeng, et al.
Publicado: (2021)

Oculoleptomeningeal Amyloidosis associated with transthyretin Leu12Pro in an African patient
por: McColgan, P., et al.
Publicado: (2014)

Clinicopathological features associated with the BAG3-Pro209Leu mutation
por: Schänzer, A., et al.
Publicado: (2018)

Association of glutathione peroxidase-1 (GPx-1) rs1050450 Pro198Leu and Pro197Leu polymorphisms with cardiovascular risk: a meta-analysis of observational studies
por: Zhang, Jun-Xia, et al.
Publicado: (2014)

Metachromatic leukodystrophy: Characterization of two (p.Leu433Val, p.Gly449Arg) arylsulfatase A mutations
por: Wang, Yangyang, et al.
Publicado: (2019)

Theragra chalcogramma Hydrolysates, Rich in Gly-Leu-Pro-Ser-Tyr-Thr, Exerts Anti-Photoaging Potential via Targeting MAPK and NF-κB Pathways in SD Rats
por: Xu, Defeng, et al.
Publicado: (2022)

NH(2)-Terminal Pro–Brain Natriuretic Peptide and Risk of Diabetes
por: Lazo, Mariana, et al.
Publicado: (2013)

The Molecular Mechanism of Positive Allosteric Modulation at the Dopamine D1 Receptor
por: Goldberg, Alexander, et al.
Publicado: (2023)

The molecular mechanism of positive allosteric modulation at the dopamine D1 receptor
por: Goldberg, Alexander, et al.
Publicado: (2023)

Peptidomimetics in cancer targeting
por: Gomari, Mohammad Mahmoudi, et al.
Publicado: (2022)

The action of a negative allosteric modulator at the dopamine D(2) receptor is dependent upon sodium ions
por: Draper-Joyce, Christopher J., et al.
Publicado: (2018)

Determination of Hexapeptide ALA-ASP-LEU-LYS-PRO-THR by MALDI MS
por: Olejnik, Anna, et al.
Publicado: (2012)

Sesquiterpene binding Gly-Leu-Ser/Lys-“co-adaptation pocket” to inhibit lung cancer cell epithelial–mesenchymal transition
por: Ai, Xiao-Yu, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_6f86tc3qdc83dt2geaqs1mi655